Fentanyl patches should be securely stored out of the sight and reach of children and disposed of properly, advises Food and Drug Administration (FDA).

FDA has issued new dosing recommendations for sleep aids containing zolpidem.

A recent study conducted by Winchester Medical Center in Winchester, VA, shows that involving pharmacists and pharmacy technicians in the hospital admissions process reduced medication errors.

FDA alerts the public that certain over-the-counter (OTC) products that are applied to the skin for the relief of mild muscle and joint pain have been reported to cause rare cases of serious skin injuries. These OTC topical muscle and...

Food and Drug Administration (FDA) warns that consumers should not use Reumofan Plus products due to serious health risks related to the presence of prescription drug ingredients not listed on product labels. In a news release, FDA explains that the...

FDA issued a safety alert notifying consumers about the recall of Reumofan Plus, a product marketed as a natural dietary supplement for pain relief and other serious conditions. The product contains several active pharmaceutical ingredients not listed on the label...

Published in the November 2009 Ohio State Board of Pharmacy Newsletter The Ohio Department of Health (ODH) compiles statistics on many different health-related topics every year and tries to monitor trends so that action can be taken when needed. Just...